Patent ID: 8557560
Filing Date: 2013-10-15
Classification: A23C,A23L,A23V,A61K,A61P,C12N,C12Q,C12R

Abstract:
1. A probiotic strain or a mixture of strains consisting of lactic acid bacteria or bifidobacteria strains present in the fresh milk from a mammalian species selected in lactic acid culture media, wherein said probiotic strain or mixture of strains (i) are capable of being transferred to the mammary gland after oral intake and/or colonise the mammary gland after its topical application, (ii) are able to reduce the rates of survival and/or the rates of adhesion to epithelial cells of Staphylococcus aureus , and (iii) capable of protecting animals from mastitis, characterised in that the strain is selected from the group consisting of Bifidobacterium breve deposited in the CECT under Accession No. 7263 , Bifidobacterium breve deposited in the CECT under Accession No. 7264 , Lactobacillus reuteri deposited in the CECT under Accession No. 7260 , Lactobacillus plantarum deposited in the CECT under Accession No. 7262 , Lactobacillus fennenturn in the CECT under Accession No. 7265 and Lactobacillus reuteri deposited in the CECT under Accession No. 7266 , Enterococcus hirae deposited in the CECT under Accession No. 7410 , Lactobacillus plantarum deposited in the CECT under Accession No. 7412 , Enterococcus faecalis deposited in the CECT under Accession No. 7411 , Lactobacillus salivarius deposited in the CECT under Accession No. 7409 , Lactobacillus reuteri deposited in the CECT under Accession No. 7413.